ATE536419T1 - Transposon basiertes targeting- system - Google Patents
Transposon basiertes targeting- systemInfo
- Publication number
- ATE536419T1 ATE536419T1 AT04709610T AT04709610T ATE536419T1 AT E536419 T1 ATE536419 T1 AT E536419T1 AT 04709610 T AT04709610 T AT 04709610T AT 04709610 T AT04709610 T AT 04709610T AT E536419 T1 ATE536419 T1 AT E536419T1
- Authority
- AT
- Austria
- Prior art keywords
- transposase
- binding domain
- dna
- poly
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03002638 | 2003-02-10 | ||
| PCT/EP2004/001221 WO2004070042A1 (en) | 2003-02-10 | 2004-02-10 | Transposon-based targeting system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE536419T1 true ATE536419T1 (de) | 2011-12-15 |
Family
ID=32842695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04709610T ATE536419T1 (de) | 2003-02-10 | 2004-02-10 | Transposon basiertes targeting- system |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8420386B2 (de) |
| EP (1) | EP1594973B1 (de) |
| JP (1) | JP2006518204A (de) |
| AT (1) | ATE536419T1 (de) |
| DK (1) | DK1594973T3 (de) |
| WO (1) | WO2004070042A1 (de) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040172667A1 (en) | 2002-06-26 | 2004-09-02 | Cooper Richard K. | Administration of transposon-based vectors to reproductive organs |
| US7527966B2 (en) * | 2002-06-26 | 2009-05-05 | Transgenrx, Inc. | Gene regulation in transgenic animals using a transposon-based vector |
| WO2005062881A2 (en) | 2003-12-24 | 2005-07-14 | Transgenrx, Inc. | Gene therapy using transposon-based vectors |
| JP2008092911A (ja) * | 2006-10-16 | 2008-04-24 | Univ Of Tokyo | タンパク質結合検出方法 |
| EP2067402A1 (de) | 2007-12-07 | 2009-06-10 | Max Delbrück Centrum für Molekulare Medizin (MDC) Berlin-Buch; | Transposon-vermittelte Mutagenese in Spermatogoniestammzellen |
| WO2010036976A2 (en) | 2008-09-25 | 2010-04-01 | Transgenrx, Inc. | Novel vectors for production of antibodies |
| US9157097B2 (en) | 2008-09-25 | 2015-10-13 | Proteovec Holding, L.L.C. | Vectors for production of growth hormone |
| US8735156B2 (en) | 2008-12-01 | 2014-05-27 | The Board Of Regents Of The University Of Texas System | Production and use of rat spermatogonial stem cell lines |
| WO2010118360A1 (en) | 2009-04-09 | 2010-10-14 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Production of proteins using transposon-based vectors |
| US9951386B2 (en) | 2014-06-26 | 2018-04-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| US10584381B2 (en) | 2012-08-14 | 2020-03-10 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US9701998B2 (en) | 2012-12-14 | 2017-07-11 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10323279B2 (en) | 2012-08-14 | 2019-06-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| WO2014028537A1 (en) | 2012-08-14 | 2014-02-20 | 10X Technologies, Inc. | Microcapsule compositions and methods |
| US10273541B2 (en) | 2012-08-14 | 2019-04-30 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| EP2740353A1 (de) | 2012-12-06 | 2014-06-11 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Neuartige induzierbare Tiermodelle für Stressverhalten |
| US10533221B2 (en) | 2012-12-14 | 2020-01-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| CA2894694C (en) | 2012-12-14 | 2023-04-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| EP3862435A1 (de) | 2013-02-08 | 2021-08-11 | 10X Genomics, Inc. | Polynukleotid-strichcodegenerierung |
| WO2014143383A1 (en) * | 2013-03-13 | 2014-09-18 | Agilent Technologies, Inc. | Transposome tethered to a gene delivery vehicle |
| JP6618894B2 (ja) | 2013-05-23 | 2019-12-11 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 個別的エピゲノミクスのための天然クロマチンへの転移 |
| AU2015243445B2 (en) | 2014-04-10 | 2020-05-28 | 10X Genomics, Inc. | Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same |
| CN106795553B (zh) | 2014-06-26 | 2021-06-04 | 10X基因组学有限公司 | 分析来自单个细胞或细胞群体的核酸的方法 |
| CA2964472A1 (en) | 2014-10-29 | 2016-05-06 | 10X Genomics, Inc. | Methods and compositions for targeted nucleic acid sequencing |
| US9975122B2 (en) | 2014-11-05 | 2018-05-22 | 10X Genomics, Inc. | Instrument systems for integrated sample processing |
| EP3244992B1 (de) | 2015-01-12 | 2023-03-08 | 10X Genomics, Inc. | Verfahren zur barcodierung von nukleinsäuresen |
| BR112017018054A2 (pt) | 2015-02-24 | 2018-07-24 | 10X Genomics Inc | métodos para a cobertura de sequências de ácidos nucleicos direcionadas |
| EP3262407B1 (de) | 2015-02-24 | 2023-08-30 | 10X Genomics, Inc. | Partitionsverarbeitungsverfahren und -systeme |
| SG10202108763UA (en) | 2015-12-04 | 2021-09-29 | 10X Genomics Inc | Methods and compositions for nucleic acid analysis |
| WO2017197338A1 (en) | 2016-05-13 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic systems and methods of use |
| EP3508574A4 (de) * | 2016-08-30 | 2020-04-01 | Kyushu University, National University Corporation | Verfahren zum einfügen eines gewünschten dna-fragments in eine stelle neben einer bindungsdomäne eines dna-bindenden proteins |
| CA3047313A1 (en) | 2016-12-16 | 2018-06-21 | B-Mogen Biotechnologies, Inc. | Enhanced hat family transposon-mediated gene transfer and associated compositions, systems, and methods |
| US11278570B2 (en) | 2016-12-16 | 2022-03-22 | B-Mogen Biotechnologies, Inc. | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |
| US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10011872B1 (en) | 2016-12-22 | 2018-07-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| WO2018140966A1 (en) | 2017-01-30 | 2018-08-02 | 10X Genomics, Inc. | Methods and systems for droplet-based single cell barcoding |
| WO2018195129A1 (en) | 2017-04-17 | 2018-10-25 | University Of Maryland, College Park | Embryonic cell cultures and methods of using the same |
| US10844372B2 (en) | 2017-05-26 | 2020-11-24 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
| SG11201901822QA (en) | 2017-05-26 | 2019-03-28 | 10X Genomics Inc | Single cell analysis of transposase accessible chromatin |
| SG11201913654QA (en) | 2017-11-15 | 2020-01-30 | 10X Genomics Inc | Functionalized gel beads |
| US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
| SG11202009889VA (en) | 2018-04-06 | 2020-11-27 | 10X Genomics Inc | Systems and methods for quality control in single cell processing |
| JP2021527427A (ja) | 2018-06-21 | 2021-10-14 | ビー−モーゲン・バイオテクノロジーズ，インコーポレーテッド | 強化されたｈＡＴファミリーのトランスポゾンが介在する遺伝子導入ならびに関連する組成物、システム、及び方法 |
| CA3118146A1 (en) * | 2018-11-08 | 2020-05-14 | Summation Bio, Inc. | Mini-nucleosome core proteins and use in nucleic acid delivery |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1334350A (en) * | 1916-08-11 | 1920-03-23 | Jr Edward T Condon | Automatic stop mechanism for talking-machines |
| AU7097494A (en) * | 1993-06-01 | 1994-12-20 | Targeted Genetics Corporation | Envelope fusion vectors for use in gene delivery |
| WO1998040510A1 (en) | 1997-03-11 | 1998-09-17 | Regents Of The University Of Minnesota | Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
| WO1999005295A1 (en) * | 1997-07-25 | 1999-02-04 | Thomas Jefferson University | Composition and method for targeted integration into cells |
| AU1100201A (en) | 1999-10-28 | 2001-05-08 | Board Of Trustees Of The Leland Stanford Junior University | Methods of in vivo gene transfer using a sleeping beauty transposon system |
| CA2416664A1 (en) | 2000-07-21 | 2002-01-31 | Syngenta Participations Ag | Zinc finger domain recognition code and uses thereof |
| US7431922B2 (en) * | 2002-03-29 | 2008-10-07 | Tissuegene, Inc. | Bioadhesive directed somatic cell therapy |
| DE60335637D1 (de) * | 2002-07-24 | 2011-02-17 | Manoa Biosciences Inc | Vektoren auf transposonbasis und verfahren zur integration von nukleinsäuren |
| WO2004069995A2 (en) * | 2003-02-10 | 2004-08-19 | Max-Delbrück-Centrum Für Molekulare Medizin (Mdc) | Transposon-based targeting system |
-
2004
- 2004-02-10 AT AT04709610T patent/ATE536419T1/de active
- 2004-02-10 EP EP04709610A patent/EP1594973B1/de not_active Expired - Lifetime
- 2004-02-10 DK DK04709610.2T patent/DK1594973T3/da active
- 2004-02-10 WO PCT/EP2004/001221 patent/WO2004070042A1/en active Application Filing
- 2004-02-10 US US10/544,971 patent/US8420386B2/en active Active
- 2004-02-10 JP JP2006501791A patent/JP2006518204A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004070042A1 (en) | 2004-08-19 |
| US8420386B2 (en) | 2013-04-16 |
| EP1594973A1 (de) | 2005-11-16 |
| US20060258603A1 (en) | 2006-11-16 |
| DK1594973T3 (da) | 2012-02-13 |
| EP1594973B1 (de) | 2011-12-07 |
| JP2006518204A (ja) | 2006-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE536419T1 (de) | Transposon basiertes targeting- system | |
| DK1594971T3 (da) | Transposonbaseret målretningssystem | |
| MX348154B (es) | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. | |
| SG162687A1 (en) | Caustic stable chromatography ligands | |
| PH12015501848A1 (en) | Binding agents | |
| WO2005056759A3 (en) | Methods of generating variant proteins with increased host string content and compositions thereof | |
| ATE408624T1 (de) | Verfahren zur reinigung von fsh | |
| EA200700917A1 (ru) | Способ рефолдинга рекомбинантных антител | |
| WO2006033859A3 (en) | Compositions and methods for protein production | |
| MY174493A (en) | Binding agents | |
| DE602004025101D1 (de) | Humane anti-humane cd3-bindungsmoleküle | |
| EA200701192A1 (ru) | Антагонисты toll-подобного рецептора 3, способы их получения и применение | |
| DK1594972T3 (da) | Transposon-baseret målretningssystem | |
| WO2007115571A8 (en) | Erbb receptor-derived peptide fragments | |
| NZ598770A (en) | Monoclonal antibodies | |
| EA201100070A1 (ru) | Туберкулезный белок rv2386c, композиции и их применения | |
| TW200745159A (en) | IL-6 binding proteins | |
| DK1519944T3 (da) | Fremgangsmåder til fremstilling af fibrinogen | |
| WO2006132739A3 (en) | Novel chemical compounds | |
| WO2002024912A3 (en) | Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof | |
| WO2010142551A8 (en) | Amino acid sequences directed against receptors to cytokines belonging to the il-17 family | |
| WO2007045019A3 (en) | Polyoleosins | |
| IL175646A0 (en) | Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof | |
| WO2006127458A3 (en) | Novel chemical compounds | |
| WO2006097336A3 (en) | A novel component of the wg/wnt signaling pathway |